News & CommentCanada

Drug Industry Misses Target for Funding Work on Campus

+ See all authors and affiliations

Science  03 Jan 1997:
Vol. 275, Issue 5296, pp. 23-24
DOI: 10.1126/science.275.5296.23

You are currently viewing the summary.

View Full Text

Summary

Ottawa—Canadian drug companies won over academic researchers in their successful campaign 3 years ago to extend patent protection for brand-name drugs by promising to spend $200 million on university research. The industry hasn't kept its promise, however, and there's plenty of finger-pointing as the government prepares to look at what has happened.

Related Content